21.00
-0.50
(-2.33%)
May 20 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
| Range | - |
| 52 week | 8.50 - 29.00 |
| Open | 21.50 |
| Vol / Avg. | 0.00/2,702.00 |
| Mkt cap | 4.07M* |
| P/E | 17.99 |
| Div/yield | - |
| EPS | 0.01* |
| Shares | 19.37M |
| Beta | - |
| Inst. own | - |
| *GBP |
Key stats and ratios
| Q4 (Oct '12) | 2012 | |
| Net profit margin | 0.29% | 0.28% |
| Operating margin | 1.15% | 1.17% |
| EBITD margin | - | 8.54% |
| Return on average assets | 0.56% | 0.53% |
| Return on average equity | 1.16% | 1.06% |
| Employees | 47 | - |
| Carbon Disclosure Rating | - | - |
Address
Beacon House, Nuffield Road
CAMBRIDGE, ENG CB4 1TF
United Kingdom - Map
+44-1223-727144 (Phone)
+44-1223-727101 (Fax)
CAMBRIDGE, ENG CB4 1TF
United Kingdom - Map
+44-1223-727144 (Phone)
+44-1223-727101 (Fax)
Website links
External links
Analyst Estimates - BusinessWeek
Options - MarketWatch
Research Reports - Reuters
Director Dealings - Yahoo Finance
Discussion Group - Google Finance
Advertisement
Description
Scientific Digital Imaging plc (SDI) is a United Kingdom-based company. SDI is focused on the application of digital imaging technology to the needs of the scientific community. The Company operates is a single segment being the supply of digital imaging equipment, encompassing Synoptics three marketing brands: Syngene, Synbiosis, Syncroscopy and the Alik brand. SDI through its subsidiaries offers a range of digital imaging solutions. The Company�s principal subsidiary, Synoptics Limited, is engaged in designing and manufacturing special-purpose instruments for use in the life sciences. Synoptics offers its products through for divisions: Syngene, Synbiosis, Syncroscopy and Synoptics Health. The Company�s subsidiaries include Synoptics Limited, Artemis CCD Limited, Perseu Comercio De Equipamento Para Informatica E Astronomica SA.
Officers and directors
| Michael John Creedon | Chief Executive Officer, Executive Director | |
| Eric Kenelm Ford | Non-Executive Independent Chairman of the Board | |
| Jeremy Stephen Gibbs | Non-Executive Deputy Chairman of the Board | |
| Ann Juliet Bateman Simon | Non-Executive Independent Director |